Passage Bio, Inc. (PASG)
4.52
+0.19
(+4.39%)
USD |
NASDAQ |
Aug 28, 16:00
4.57
+0.05
(+1.11%)
After-Hours: 20:00
Passage Bio Total Assets (Quarterly) : 25.18M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 25.18M |
| March 31, 2026 | 36.46M |
| December 31, 2025 | 62.28M |
| September 30, 2025 | 74.16M |
| June 30, 2025 | 79.20M |
| March 31, 2025 | 86.01M |
| December 31, 2024 | 102.41M |
| September 30, 2024 | 111.75M |
| June 30, 2024 | 125.39M |
| March 31, 2024 | 140.53M |
| December 31, 2023 | 150.54M |
| September 30, 2023 | 169.26M |
| June 30, 2023 | 193.70M |
| March 31, 2023 | 213.24M |
| December 31, 2022 | 243.55M |
| September 30, 2022 | 270.05M |
| Date | Value |
|---|---|
| June 30, 2022 | 299.42M |
| March 31, 2022 | 333.22M |
| December 31, 2021 | 355.08M |
| September 30, 2021 | 390.94M |
| June 30, 2021 | 439.52M |
| March 31, 2021 | 465.17M |
| December 31, 2020 | 328.01M |
| September 30, 2020 | 358.69M |
| June 30, 2020 | 378.10M |
| March 31, 2020 | 392.43M |
| December 31, 2019 | 178.61M |
| September 30, 2019 | 188.98M |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 33.46M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ARS Pharmaceuticals, Inc. | 249.50M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 20.72M |
| Shareholders Equity (Quarterly) | 4.456M |
| Current Ratio | 1.215 |
| Net Debt Paydown Yield | 31.99% |